多发性硬化症的新治疗途径:基于肠道微生物群的治疗方法是否存在?
Lucrezia Irene Maria Campagnoli1, Nicoletta Marchesi1, Angelica Varesi2
1Department of Drug Sciences, Section of Pharmacology, University of Pavia, Pavia, Italy.
Pharmacological research
|October 10, 2024
概括
肠道微生物群-大脑轴影响大脑功能和神经退行性疾病,如多发性硬化症 (MS). 恢复肠道微生物群可以通过改善肠道健康和减少炎症来帮助预防或管理多发性硬化.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群-大脑轴调节中枢神经系统功能和神经退行性疾病的进展.
- 多发性硬化症 (MS) 与胃肠道问题和改变肠道微生物群 (GM) 组成有关.
- 转基因生物失调可能通过增加肠道透性,炎症和免疫细胞变化导致MS病理.
研究的目的:
- 审查肠道微生物群改变在多发性硬化症发病过程中的作用.
- 探索针对MS管理的转基因恢复的预防策略.
主要方法:
- 在MS的肠道微生物群-大脑轴研究的文献综述.
- 对将转基因生物失调与MS特征联系起来的证据分析.
- 对转基因调节的治疗干预措施的探索.
主要成果:
- 在MS患者中观察到改变的转基因成分.
- 转基因生物失调与关键的MS病理特征有关.
- 恢复转基因平衡显示了MS预防和管理的潜力.
结论:
- 肠道微生物群的改变与MS的发病有关.
- 诸如饮食,益生菌,益生菌,共生菌,后生菌和FMT等干预措施可能会恢复转基因.
- 转基因恢复可能是MS预防和治疗的补充策略.
相关概念视频
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Irritable Bowel Syndrome I: Introduction
254
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
254


